Pharmalex US Corporation

Conshohocken, PA Part of Cencora, Inc.

UEI
XFLXMFKCJQN1
CAGE
884Z0
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
  • Amerisourcebergen Parent Cencora, Inc. · Conshohocken, PA NWEGNLYTBDW4
    • Pharmalex US Corporation
SAM.gov registration date
Physical address
1 W 1st Ave, Conshohocken, PA 19428, USA
Website
pharmalex.com
Founded
1994
Employees
1K-5K
Estimated annual revenue
$500M-$1B
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
89 Services, Not Elsewhere Classified
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $28,000
FY2023 $24,250

Contract awards

Award Agency Obligated Awarded
Biologics subject matter expert (SME) consulting services 75N95022P00209 National Institute on Drug Abuse (NIH) $62,950

Contract subawards

Prime contractor Prime award Amount Awarded
Modernatx, Inc. DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN… 75A50120C00034 $150,000

Quick answers

Is Pharmalex US Corporation registered in SAM.gov?

Yes. Pharmalex US Corporation's SAM.gov registration is active through March 27, 2027.

What is Pharmalex US Corporation's CAGE code?

Pharmalex US Corporation's CAGE code is 884Z0, and its Unique Entity ID (UEI) is XFLXMFKCJQN1.

How much has Pharmalex US Corporation received in federal contracts?

Federal contracts obligated $52,250 to Pharmalex US Corporation in fiscal years 2023 through 2027.

What is Pharmalex US Corporation's most recent federal award?

Pharmalex US Corporation's most recent federal contract award is Biologics subject matter expert (SME) consulting services (75N95022P00209), from National Institute on Drug Abuse (NIH), on April 15, 2022.

On GovTribe

See Pharmalex US Corporation's full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe